Home | Cancers | Prostate Cancer

Prostate Cancer

FDA approves new diagnostic imaging agent to detect recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography ...

FDA approves new diagnostic imaging agent to detect recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography ...

Study Finds Potential Benefit in Combination Prostate Cancer Immunotherapy

Madison, Wisconsin — A new study from University of Wisconsin Carbone Cancer Center researchers suggests that a combination immunotherapy approach could lead to increased survival for prostate cancer patients. ... Full story

NewYork-Presbyterian and Weill Cornell Medicine Doctors Discuss the Future of Prostate Cancer Screening

In the May 5 issue of the New England Journal of Medicine, Dr. Jonathan Shoag, a resident in the Department of Urology at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, and Dr. Jim C. Hu, director of the LeFrak Center for Robotic Surgery at NewYork-Presbyterian/Weill Cornell and the Ronald Lynch Professor of Urologic Oncology at Weill Cornell Medicine, call into question a landmark study that served as the basis for national prostate cancer screening recommendations. ... Full story

Radiotherapy halves deaths from prostate cancer 15 years after diagnosis

A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of death from prostate cancer 15 years after diagnosis. This according to a follow-up study recently published in the journal European Urology. ... Full story

New England Journal of Medicine Letter to the Editor Calls Prostate Cancer Screening Guidelines into Question

NewYork-Presbyterian and Weill Cornell Medicine urologists urge reconsideration of prostate cancer screening after finding critical flaw in landmark study ... Full story

Streamlined approach and treatments improve the quality of care for men with prostate cancer

The quality of prostate cancer care is improving according to new Monash University research published today in The Medical Journal of Australia. ... Full story

New Model for Active Surveillance of Prostate Cancer Tested

Physician-led quality initiative improves patient care, prevents overtreatment ... Full story

Sanda to lead multi-center prostate cancer biomarker study

The Emory, Harvard, and University of Washington Prostate Cancer Biomarker Center has received a $4.2 million grant from the National Cancer Institute's Early Detection Research Network to develop multiplex tests for detecting prostate cancer. ... Full story

New technology quantifies effects of prostate tumor laser ablation

Effort to understand risks of treatment, and prognostic clues to long-term outcomes ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 288 | displaying: 1 - 10